Patent Yard Sign in
Canadian application, no grantCanada

Method and formula for anti-tumor and anti-matastatic effect

CA 2442396 A1 · Owner: Giles, Brian C. · Inventors: Giles, Brian C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention discloses an expeditious method and formula for treating cancer patients that reaulst in tumor suppression and remission the suppression of , mobilization and adhesion of cancer cells and repression of pathogens, such , as infectious bacteria and viruses. Administration is by oral ingestion or direct injection into tumors or intravenous drip etc. The invention employs control of intracellular and extracelular ionic physiology by administering alkaline salts, thereby restoring localized and/or systemic cellular ionic physiology, depriving cancerous cells of their ability to grow rapidly and , simultaneously normalizing their local environment thereby inhibiting , …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 28, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 28, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 28, 2001
GrantedNo grant recorded
Term endedFebruary 28, 2021
Patent numberCA 2442396 A1
Classification (IPC)A61K31/18 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedFeb 28, 2001Term endedFeb 28, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.